Nukosh Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -47.08%
- Ebitda -47.08%
- Net Worth -107.00%
- Total Assets -28.13%
About Nukosh Biotech
Nukosh Biotech Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 April 2019 (Five years and nine months 4 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shubhangi Wagh, Shashank Wagh, and Ramesh Kogekar serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110PN2019PTC183823
-
Company No.
183823
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Apr 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Nukosh Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubhangi Wagh
|
Director | 16-Jun-2021 | Current |
|
Shashank Wagh
|
Director | 02-Sep-2024 | Current |
|
Ramesh Kogekar
|
Director | 30-Apr-2019 | Current |
Financial Performance of Nukosh Biotech.
Nukosh Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 47.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 107%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nukosh Biotech?
In 2022, Nukosh Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Smart Tech Equipments Private LimitedShubhangi Wagh and Shashank Wagh are mutual person
-
Geetamrut Agro Estate Private Limited
Shashank Wagh is a mutual person
-
Swargamrut Agro Estate Private Limited
Shashank Wagh is a mutual person
-
Multiventure Estates Private Limited
Shashank Wagh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nukosh Biotech?
Unlock and access historical data on people associated with Nukosh Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nukosh Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nukosh Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
